Literature DB >> 21481787

Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression.

Akihisa Fukuda1, Sam C Wang, John P Morris, Alexandra E Folias, Angela Liou, Grace E Kim, Shizuo Akira, Kenneth M Boucher, Matthew A Firpo, Sean J Mulvihill, Matthias Hebrok.   

Abstract

Chronic pancreatitis is a well-known risk factor for pancreatic ductal adenocarcinoma (PDA) development in humans, and inflammation promotes PDA initiation and progression in mouse models of the disease. However, the mechanistic link between inflammatory damage and PDA initiation is unclear. Using a Kras-driven mouse model of PDA, we establish that the inflammatory mediator Stat3 is a critical component of spontaneous and pancreatitis-accelerated PDA precursor formation and supports cell proliferation, metaplasia-associated inflammation, and MMP7 expression during neoplastic development. Furthermore, we show that Stat3 signaling enforces MMP7 expression in PDA cells and that MMP7 deletion limits tumor size and metastasis in mice. Finally, we demonstrate that serum MMP7 level in human patients with PDA correlated with metastatic disease and survival.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21481787      PMCID: PMC3075548          DOI: 10.1016/j.ccr.2011.03.002

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  55 in total

Review 1.  Renaming cytokines: MCP-1, major chemokine in pancreatitis.

Authors:  F Marra
Journal:  Gut       Date:  2005-06-15       Impact factor: 23.059

2.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Recapitulation of elements of embryonic development in adult mouse pancreatic regeneration.

Authors:  Jan Nygaard Jensen; Erin Cameron; Maria Veronica R Garay; Thomas W Starkey; Roberto Gianani; Jan Jensen
Journal:  Gastroenterology       Date:  2005-03       Impact factor: 22.682

4.  Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.

Authors:  Y Adachi; H Yamamoto; F Itoh; Y Hinoda; Y Okada; K Imai
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

5.  MMP-7 promotes prostate cancer-induced osteolysis via the solubilization of RANKL.

Authors:  Conor C Lynch; Atsuya Hikosaka; Heath B Acuff; Michelle D Martin; Noriyasu Kawai; Rakesh K Singh; Tracy C Vargo-Gogola; Jennifer L Begtrup; Todd E Peterson; Barbara Fingleton; Tomoyuki Shirai; Lynn M Matrisian; Mitsuru Futakuchi
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

6.  Chemokine gene expression in rat pancreatic acinar cells is an early event associated with acute pancreatitis.

Authors:  T Grady; P Liang; S A Ernst; C D Logsdon
Journal:  Gastroenterology       Date:  1997-12       Impact factor: 22.682

7.  Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse.

Authors:  Nabeel Bardeesy; Andrew J Aguirre; Gerald C Chu; Kuang-Hung Cheng; Lyle V Lopez; Aram F Hezel; Bin Feng; Cameron Brennan; Ralph Weissleder; Umar Mahmood; Douglas Hanahan; Mark S Redston; Lynda Chin; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

8.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice.

Authors:  K Takeda; T Kaisho; N Yoshida; J Takeda; T Kishimoto; S Akira
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

9.  Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.

Authors:  Lucie E Jones; Michelle J Humphreys; Fiona Campbell; John P Neoptolemos; Mark T Boyd
Journal:  Clin Cancer Res       Date:  2004-04-15       Impact factor: 12.531

10.  Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

Authors:  C Almoguera; D Shibata; K Forrester; J Martin; N Arnheim; M Perucho
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

View more
  262 in total

Review 1.  Genetically Engineered Mouse Models of K-Ras-Driven Lung and Pancreatic Tumors: Validation of Therapeutic Targets.

Authors:  Matthias Drosten; Carmen Guerra; Mariano Barbacid
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

2.  Suppressive Effects of Plumbagin on Invasion and Migration of Breast Cancer Cells via the Inhibition of STAT3 Signaling and Down-regulation of Inflammatory Cytokine Expressions.

Authors:  Wei Yan; Bing Tu; Yun-Yun Liu; Ting-Yu Wang; Han Qiao; Zan-Jing Zhai; Hao-Wei Li; Ting-Ting Tang
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

3.  JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer.

Authors:  Chunwan Lu; Asif Talukder; Natasha M Savage; Nagendra Singh; Kebin Liu
Journal:  Oncoimmunology       Date:  2017-02-10       Impact factor: 8.110

Review 4.  Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.

Authors:  Constantinos P Zambirinis; George Miller
Journal:  Trends Mol Med       Date:  2017-04-08       Impact factor: 11.951

Review 5.  From tissue turnover to the cell of origin for pancreatic cancer.

Authors:  Bo Kong; Christoph W Michalski; Mert Erkan; Helmut Friess; Jörg Kleeff
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-12       Impact factor: 46.802

Review 6.  Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence.

Authors:  Veronique Giroux; Anil K Rustgi
Journal:  Nat Rev Cancer       Date:  2017-09-01       Impact factor: 60.716

7.  Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance.

Authors:  Yaqing Zhang; Wei Yan; Meredith A Collins; Filip Bednar; Sabita Rakshit; Bruce R Zetter; Ben Z Stanger; Ivy Chung; Andrew D Rhim; Marina Pasca di Magliano
Journal:  Cancer Res       Date:  2013-10-04       Impact factor: 12.701

8.  Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses.

Authors:  Jonathan B Mitchem; Donal J Brennan; Brett L Knolhoff; Brian A Belt; Yu Zhu; Dominic E Sanford; Larisa Belaygorod; Danielle Carpenter; Lynne Collins; David Piwnica-Worms; Stephen Hewitt; Girish Mallya Udupi; William M Gallagher; Craig Wegner; Brian L West; Andrea Wang-Gillam; Peter Goedegebuure; David C Linehan; David G DeNardo
Journal:  Cancer Res       Date:  2012-12-05       Impact factor: 12.701

9.  Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.

Authors:  Weiying Zhang; Nivedita Nandakumar; Yuhao Shi; Mark Manzano; Alias Smith; Garrett Graham; Swati Gupta; Eveline E Vietsch; Sean Z Laughlin; Mandheer Wadhwa; Mahandranauth Chetram; Mrinmayi Joshi; Fen Wang; Bhaskar Kallakury; Jeffrey Toretsky; Anton Wellstein; Chunling Yi
Journal:  Sci Signal       Date:  2014-05-06       Impact factor: 8.192

Review 10.  Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review.

Authors:  Eckhard Klieser; Stefan Swierczynski; Christian Mayr; Tarkan Jäger; Johanna Schmidt; Daniel Neureiter; Tobias Kiesslich; Romana Illig
Journal:  World J Gastrointest Pathophysiol       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.